Generation of dual functional nanobody-nanoluciferase fusion and its potential in bioluminescence enzyme immunoassay for trace glypican-3 in serum
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation of dual functional nanobody-nanoluciferase fusion and its potential in bioluminescence enzyme immunoassay for trace glypican-3 in serum
Authors
Keywords
Anti-GPC3 binder, Nanobody/nanoluciferase fusion, Bioluminescence enzyme immunoassay, Diagnosis for HCC
Journal
SENSORS AND ACTUATORS B-CHEMICAL
Volume 336, Issue -, Pages 129717
Publisher
Elsevier BV
Online
2021-03-03
DOI
10.1016/j.snb.2021.129717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays
- (2020) Qizhong Lu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
- (2020) Lijie Xia et al. International Journal of Nanomedicine
- The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis
- (2020) Shoujie Zhao et al. Annals of Translational Medicine
- An Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Heptamer Fusion for the Detection of Tetrabromobisphenol A in Sediment
- (2020) Zhenfeng Li et al. ANALYTICAL CHEMISTRY
- Promoting Early Diagnosis and Precise Therapy of Hepatocellular Carcinoma by Glypican-3-Targeted Synergistic Chemo-Photothermal Theranostics
- (2019) Weiwei Mu et al. ACS Applied Materials & Interfaces
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis
- (2018) Dahai Xu et al. Annals of Hepatology
- Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability
- (2018) Obinna C. Ubah et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Development of a Highly Sensitive Direct Competitive Fluorescence Enzyme Immunoassay Based on a Nanobody–Alkaline Phosphatase Fusion Protein for Detection of 3-Phenoxybenzoic Acid in Urine
- (2018) Jingqian Huo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3
- (2017) Juan-Juan Chen et al. JOURNAL OF FLUORESCENCE
- Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
- (2017) Chunmei Xie et al. Scientific Reports
- VHH antibodies: emerging reagents for the analysis of environmental chemicals
- (2016) Candace S. Bever et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
- (2016) Yukihiro Haruyama WORLD JOURNAL OF GASTROENTEROLOGY
- Glypican-3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy
- (2015) Hirofumi Hanaoka et al. MOLECULAR PHARMACEUTICS
- Imaging of hepatocellular carcinoma patient-derived xenografts using 89Zr-labeled anti-glypican-3 monoclonal antibody
- (2014) Xiaoyang Yang et al. BIOMATERIALS
- Development of a Clinical Chemiluminescent Immunoassay for Serum GPC3 and Simultaneous Measurements Alone With AFP and CK19 in Diagnosis of Hepatocellular Carcinoma
- (2014) Juan-Ping Yu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
- (2013) Min Chen et al. CLINICA CHIMICA ACTA
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preparation and Characterization of Monoclonal Antibody Against Glypican-3
- (2012) Rui-juan Ma et al. HYBRIDOMA
- High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
- (2012) Yen Phung et al. mAbs
- Isolation of Alpaca Anti-Hapten Heavy Chain Single Domain Antibodies for Development of Sensitive Immunoassay
- (2011) Hee-Joo Kim et al. ANALYTICAL CHEMISTRY
- Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma
- (2010) Qianyun Zhang et al. CLINICAL BIOCHEMISTRY
- Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
- (2010) Eisuke Yasuda et al. HEPATOLOGY RESEARCH
- Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface
- (2008) Alexandra Traister et al. BIOCHEMICAL JOURNAL
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search